biotech

More than 400 Biotechnology Drugs and Vaccines Under Trials

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on August 16, 2006

More than 400 Biotechnology Drugs and Vaccines Under Trials
A new report (pdf file) from the Pharmaceutical Research and Manufacturers Association (PhRMA) found 418 medicines and vaccines developed through biotechnology in various stages of development to treat more than 100 diseases. The breakdown:
  • 210 medicines to treat cancer

  • 50 to treat infectious disease

  • 44 to treat autoimmune disorders

  • 22 to treat HIV Infection and related-conditions and

  • 22 to treat cardiovascular diseases



The report also highlights biotech drugs such as:
  • monoclonal antibodies targeting asthma, lupus and various types of cancer

  • vaccines designed against AIDS and cancer

  • antisense products as potential treatments for cancer and heart disease

  • gene therapy testing in cancer and heart disease.


You may download (pdf file) the report here. You may also want to read the report backgrounder on some biotech drugs being developed to treat anemia, rheumatoid arthritis, inflammatory bowel disease, muscular dystrophy, and protate cancer.

[Source: PhRMA]


Permalink: More than 400 Biotechnology Drugs and Vaccines Under Trials

Tags: biotechnology  drugs  biotech  more  vaccines  drugs+vaccines  biotechnology+drugs  more+than 

Vote for More than 400 Biotechnology Drugs and Vaccines Under Trials:

  • Currently 8.88/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.88 out of 16 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells